BioMarin BMRN0.75%increase; green up pointing triangle Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics FOLD-0.07%decrease; red down pointing triangle for about $4.8 billion ...

Fortress Biotech ( (FBIO)) has provided an announcement. On December 15, 2025, Fortress Biotech announced that the U.S. FDA accepted the resubmission of the New Drug Application for CUTX-101 as a ...

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current momentum—as long as strong clinical data continue to be rewarded and companies ...

After layoffs this fall, Mythic Therapeutics is winding down, putting all its assets up for sale and terminating its only clinical trial. “The company is in the process of winding down and selling ...

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and ...

Thai knockout artist Jaosuayai Mor Krungthepthonburi expects a tough encounter when he battles veteran striker Sam-A Gaiyanghadao this week. He sees an even match, which could go either way. The two ...

Sam Allardyce made the headlines last week when he likened Wilfried Nancy to a 'schoolteacher' amid the struggling Celtic manager's decision to whip out his tactics board during the 2-1 loss to Hearts ...

World, the biometric ID verification project co-founded by Sam Altman, released the newest version of its app today, debuting several new features, including an encrypted chat integration and an ...

In 2025, Donald Trump's erratic, unlawful policies upended the postwar era of globalization and set in motion a process that will culminate in America's loss of global primacy. Not only are the ...

Days of heavy rain from a strong atmospheric river triggered major flooding in western Washington state that topped all-time record crests in some areas. The heavy rain during the week of December ...

Geron Corporation, a Bay Area biotech company that's ramping up sales of its first commercial drug, announced on Thursday that it's laying off a third of its staff. The Foster City drugmaker revealed ...